1901 - 1950 of 9134 Results
Title
Year
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
-
OPENTitle: Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 11Start Page: 998End Page: 1008Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30285-6Best OA location URL: http://www.thelancet.com/article/S1474442219302856/pdfCitation Count: 579
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page: 9409363End Page: 9409363Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 93
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 420
-
OPENTitle: A brain network response to sham surgeryJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 8Start Page: 3285End Page: 3288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci77193Best OA location URL: http://www.jci.org/articles/view/77193/files/pdfCitation Count: 16
-
OPENTitle: Can Parkinson’s disease be cured by stimulating neurogenesis?Journal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 3Start Page: 978End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci80822Best OA location URL: http://www.jci.org/articles/view/80822/files/pdfCitation Count: 10
-
OPENTitle: Subjective cognitive complaints are important in PD-MCI criteria: Associations with CSF markers and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105221End Page: 105221Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.11.013Best OA location URL: http://www.prd-journal.com/article/S1353802022003819/pdfCitation Count: 6
-
OPENTitle: Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 23End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.001Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7222918Citation Count: 38
-
OPENTitle: Attentional dysfunction and the punding spectrum in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 23End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7980283Citation Count: 11
-
OPENTitle: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 13End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.003Citation Count: 7
-
OPENTitle: A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100104End Page: 100104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100104Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100104Citation Count: 24
-
OPENTitle: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100177End Page: 100177Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100177Citation Count: 3
-
OPENTitle: Synergistic associations of depressive symptoms and aging on cognitive decline in early Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100192End Page: 100192Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100192Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100192Citation Count: 6
-
OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 15End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 148
- Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness2017OPENTitle: Increased dopaminergic function in the thalamus is associated with excessive daytime sleepinessJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 43Issue #:Start Page: 25End Page: 30Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2017.11.1137Citation Count: 13
-
OPENTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
OPENTitle: Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 IntegrinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 282Issue #: 44Start Page: 32222End Page: 32232Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m702899200Best OA location URL: https://doi.org/10.1074/jbc.m702899200Citation Count: 37
-
OPENTitle: Select E2 enzymes differentially regulate parkin activation and mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol:Issue #:Start Page: 3488End Page: 504Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.147520Best OA location URL: http://doi.org/10.1242/jcs.147520Citation Count: 70
-
OPENTitle: The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 51Issue #: 2Start Page: 345End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-150859Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6074044Citation Count: 96
-
OPENTitle: Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 64Issue #: 2Start Page: 597End Page: 606Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-180121Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6518401Citation Count: 101
- Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging2016OPENTitle: Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of AgingJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 65Issue #: 4Start Page: 792End Page: 799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jgs.14670Best OA location URL: http://doi.org/10.1111/jgs.14670Citation Count: 63
-
OPENTitle: Stem cells in development of therapeutics for Parkinson's disease: A perspectiveJournal Name: Journal of Cellular BiochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1153End Page: 1160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jcb.21916Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcb.21916Citation Count: 15
- Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion2011RESTRICTEDTitle: Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 124Issue #: 9Start Page: 1403End Page: 1410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.079293Citation Count: 77
-
OPENTitle: Metabolic network expression in parkinsonism: Clinical and dopaminergic correlationsJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 37Issue #: 2Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x16637880Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X16637880Citation Count: 63
-
OPENTitle: Heterogeneity of Cholinergic Denervation in Parkinson's Disease without DementiaJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 32Issue #: 8Start Page: 1609End Page: 1617Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/jcbfm.2012.60Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2012.60Citation Count: 186
-
OPENTitle: Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian miceJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 1Start Page: 149End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci32273Best OA location URL: http://doi.org/10.1172/JCI32273Citation Count: 178
-
OPENTitle: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 9Start Page: 3087End Page: 3097Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci35781Best OA location URL: http://www.jci.org/articles/view/35781/files/pdfCitation Count: 196
- Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation2009OPENTitle: Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradationJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 119Issue #: 3Start Page: 650End Page: 660Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci37617Best OA location URL: http://doi.org/10.1172/JCI37617Citation Count: 389
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 126
-
OPENTitle: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 10Start Page: 2116End Page: 2130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/10/2116.full.pdfCitation Count: 26
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 70
- Serum lipid alterations in GBA-associated Parkinson's disease2017RESTRICTEDTitle: Serum lipid alterations in GBA-associated Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 58End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026Citation Count: 90
-
OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 54
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: http://doi.org/10.1088/1741-2552/aa5238Citation Count: 51
-
OPENTitle: Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 6Start Page: 1514.e1End Page: 1514.e12Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.01.010Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2014.01.010Citation Count: 50
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 497
-
OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: http://hdl.handle.net/10871/35665Citation Count: 151
-
OPENTitle: Genetic variability in the regulation of gene expression in ten regions of the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page: 1418End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3801Best OA location URL: http://doi.org/10.1038/nn.3801Citation Count: 711
-
OPENTitle: Genetic variability at the PARK16 locusJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 18Issue #: 12Start Page: 1356End Page: 1359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ejhg.2010.125Best OA location URL: https://www.nature.com/articles/ejhg2010125.pdfCitation Count: 94
-
OPENTitle: Widespread sex differences in gene expression and splicing in the adult human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 2771End Page: 2771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/ncomms3771Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/75c8359f-d7e0-4c9d-8d86-c004995b7417Citation Count: 338
-
OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 95
-
OPENTitle: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBACJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 617Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aav1256Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7279956Citation Count: 25
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
- Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case series2024RESTRICTEDTitle: Perceptual consequences of online group speech treatment for individuals with Parkinson’s disease: A pilot study case seriesJournal Name: International Journal of Speech-Language PathologyPublisher: Informa UK LimitedVol: 27Issue #: 2Start Page: 205End Page: 220Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/17549507.2024.2330538Citation Count: 7
- Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation2018RESTRICTEDTitle: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 390Issue #:Start Page: 33End Page: 35Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002Citation Count: 2
- Balance Testing With Inertial Sensors in Patients With Parkinson's Disease: Assessment of Motor Subtypes2014RESTRICTEDTitle: Balance Testing With Inertial Sensors in Patients With Parkinson's Disease: Assessment of Motor SubtypesJournal Name: IEEE Transactions on Neural Systems and Rehabilitation EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 22Issue #: 5Start Page: 1064End Page: 1071Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tnsre.2013.2292496Citation Count: 42
-
OPENTitle: Genetic Testing for Parkinson DiseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 1Start Page: 69End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000831Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8101316Citation Count: 39
-
OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Best OA location URL: https://doaj.org/article/2232316968e3403b8d7208ad3725eaf1Citation Count: 149
-
OPENTitle: Mitochondrial therapies for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S155End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22781Best OA location URL: http://doi.org/10.1002/mds.22781Citation Count: 62